跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Oranair Plus
Approved
STANDARD
Oranair Plus
Legency Remedies Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6f567d63e1dcf310
Company
Legency Remedies Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
6f567d63e1dcf310
Drug Approval Philippines Name
Oranair Plus
Product Name
Oranair Plus
Registration Number
DRP-13475-04
Brand Name
Oranair Plus
Generic Name
Ipratropium Bromide + Salbutamol (as Sulfate)
Dosage Form
Solution for Inhalation
Dosage Strength
500 mcg/2.5 mg per 2.5 mL
Manufacturer
Legency Remedies Pvt. Ltd.
Importer
Suhitas Pharmaceuticals Inc.
Distributor
Orange Biotec Inc.
Issuance Date
26 February 2024
Expiry Date
27 February 2028
Pharmacologic Category
Adrenergic in combination with anticholinergic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6f567d63e1dcf310
Type
Standard
Back to Philippines FDA Approvals
Oranair Plus - Philippines FDA Drug Approval Details